Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Visani

Showing results (171-180 of 211) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|May 1, 1990
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patientsG Visani, C Finelli, U Castelli, et al.
Annals of Hematology|April 1, 1992
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative GroupR Willemze, N van der Lely, H Zwierzina, et al.
Haematologica|August 24, 1999
3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical featuresN Testoni, G Borsaru, G Martinelli, et al.
Bone Marrow Transplantation|January 7, 1999
Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methodsN Testoni, R M Lemoli, G Martinelli, et al.
British Journal of Haematology|August 6, 2000
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemiaG Visani, G Rosti, G Bandini, et al.
Leukemia & Lymphoma|June 1, 1997
Amplification of third-complementary-determining-region (CDR-III) of heavy chain immunoglobulin gene (IgH) in one hundred adult acute leukemiasG Martinelli, N Testoni, P Farabegoli, et al.
Leukemia & Lymphoma|December 29, 2004
Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphomaG Visani, B Guiducci, F D'Adamo, et al.
European Journal of Haematology|October 1, 1996
All-trans retinoic acid and in vitro cytokine production by acute promyelocytic leukemia cellsG Visani, P Tosi, E Ottaviani, et al.
Leukemia Research|September 27, 2016
Environmental nanoparticles are significantly over-expressed in acute myeloid leukemiaG Visani, A Manti, L Valentini, et al.
Haematologica|May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemiaM C Petti, M A Aloe Spiriti, A M Carella, et al.
Pageof 22

Showing results (171-180 of 211) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|May 1, 1990
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patientsG Visani, C Finelli, U Castelli, et al.
Annals of Hematology|April 1, 1992
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative GroupR Willemze, N van der Lely, H Zwierzina, et al.
Haematologica|August 24, 1999
3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical featuresN Testoni, G Borsaru, G Martinelli, et al.
Bone Marrow Transplantation|January 7, 1999
Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methodsN Testoni, R M Lemoli, G Martinelli, et al.
British Journal of Haematology|August 6, 2000
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemiaG Visani, G Rosti, G Bandini, et al.
Leukemia & Lymphoma|June 1, 1997
Amplification of third-complementary-determining-region (CDR-III) of heavy chain immunoglobulin gene (IgH) in one hundred adult acute leukemiasG Martinelli, N Testoni, P Farabegoli, et al.
Leukemia & Lymphoma|December 29, 2004
Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphomaG Visani, B Guiducci, F D'Adamo, et al.
European Journal of Haematology|October 1, 1996
All-trans retinoic acid and in vitro cytokine production by acute promyelocytic leukemia cellsG Visani, P Tosi, E Ottaviani, et al.
Leukemia Research|September 27, 2016
Environmental nanoparticles are significantly over-expressed in acute myeloid leukemiaG Visani, A Manti, L Valentini, et al.
Haematologica|May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemiaM C Petti, M A Aloe Spiriti, A M Carella, et al.
Pageof 22